Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 16.68M P/E - EPS this Y - Ern Qtrly Grth -
Income -9.36M Forward P/E -2.10 EPS next Y -52.10% 50D Avg Chg 11.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg 4.00%
Dividend N/A Price/Book 0.92 EPS next 5Y - 52W High Chg -63.00%
Recommedations 2.00 Quick Ratio 5.52 Shares Outstanding 11.78M 52W Low Chg 38.00%
Insider Own 4.62% ROA -35.95% Shares Float 11.24M Beta 0.71
Inst Own 10.30% ROE -57.90% Shares Shorted/Prior 98.92K/91.88K Price 1.43
Gross Margin - Profit Margin - Avg. Volume 104,958 Target Price 6.50
Oper. Margin - Earnings Date May 13 Volume 24,037 Change 0.70%
About NanoViricides, Inc.

NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. The company's product portfolio includes NV-CoV-2, nanoviricide drug which is in phase 1a/1b clinical trails for the treatment of Covid; and NV-CoV-2 Oral Syrup, and NV-CoV-2 Oral Gummies, a semi-solid fixed-dose form which are in phase 1a/1b human clinical trials for enabling body-weight-based dose titration as is required for pediatric cases. It also offers NV-CoV-2 Solution for injection, infusion, and inhalation to treat severe cases that are not yet hospitalized would be best performed by an injection; and injectable solution can be delivered directly into the lungs as a fog created using standard portable battery operated nebulizer devices which enables action at the most important site of infection by a respiratory virus, such as coronaviruses, RSV, influenzas, human meta-pneumovirus, certain adenoviruses, and other infections, that can lead to severe pneumonia. In addition, the company provides Nanoviricide, a biomimetic platform technology designed to attack enveloped virus particles to deliver anti-viral payload into infected cells sparing uninfected cells to block replication cycle without toxicity. NanoViricides, Inc. was incorporated in 2005 and is headquartered in Shelton, Connecticut.

NanoViricides, Inc. News
02/15/24 NanoViricides Has Filed its Quarterly Report - NV-387 Clinical Trial Healthy Subjects Part Successfully Completed, COVID Patient Treatment on the Horizon
02/01/24 Clinical Trial Demonstration of Safety and Tolerability of NV-CoV-2 Has Implications Beyond COVID Treatment, Explains NanoViricides - NV-387 Could be As Revolutionary as Antibiotics
01/29/24 Safety in Multiple-Ascending-Dose Healthy Subjects Clinical Trial Part Successfully Established for the NanoViricides Ultra-Broad-Spectrum Antiviral Drug NV-CoV-2 with No Adverse Events Found
01/04/24 NanoViricides to Present at the Biotech Showcase in San Fransisco
11/29/23 NanoViricides updates progress on Phase 1a/1b clinical trial of antiviral drug candidate NV-387
11/28/23 The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, Has Successfully Completed the First Part (Phase 1a), Reports NanoViricides
11/15/23 NanoViricides Has Filed its Quarterly Report - NV-387 Broad-Spectrum Antiviral in Clinical Trials Has Additional Applications
11/14/23 Broad-Spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Effective in an Animal Model for MPox and Smallpox Drug Development
10/16/23 NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 (NV-CoV-2) in Phase 1a/1b Clinical Trial is Highly Active Against Coronaviruses as well as RSV
10/12/23 NanoViricides, Inc. to Present at the Partnership Opportunities in Drug Delivery Conference in Boston on October 16, 2023 at 6:07pm ET
09/05/23 NNVC: NanoViricides Begins Clinical Trial of NV-CoV-2
08/31/23 NanoViricides progressing well with new Covid study
08/21/23 The Phase 1a/1b Human Clinical Trial of NV-CoV-2, the Company’s Broad-Spectrum Antiviral Drug, is Progressing Successfully, Reports NanoViricides
07/11/23 Company’s Broad-Spectrum Antiviral NV-387 Has Demonstrated Excellent Effectiveness in RSV in a Lethal Lung Disease Animal Model, Reports NanoViricides
07/06/23 Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs
06/29/23 NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
06/07/23 The 7 Most Promising Penny Stocks to Buy in June
05/31/23 NanoViricides, Inc. to Present at the BIO International Convention in Boston on June 5th, 2023 at 3:15pm ET
05/16/23 NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Begin
05/04/23 NanoViricides, Inc. to Present at The Inaugural Ef Hutton Global Conference on May 10, 2023 in New York City
NNVC Chatroom

User Image STRAYNUT Posted - 10 hours ago

$NNVC SHORT INTEREST (04/15/24) Shares Sold Short 112,123 Change from Last 13.35% Percent of Float 1.00% https://www.wsj.com/market-data/quotes/NNVC

User Image STRAYNUT Posted - 4 days ago

$NNVC Publications https://www.researchgate.net/profile/Anil-Diwan

User Image Love1010 Posted - 5 days ago

$NNVC The worst performing stock in the market continues to perform as the worst stock. Utter technical breakdown! I've been saying this for weeks. Foolish longs mocked me. They are always wrong @STRAYNUT

User Image FishinForCash Posted - 6 days ago

$NNVC protect your shares 30 sec read

User Image Love1010 Posted - 1 week ago

$NNVC $CODX If it's got the @straynut stamp of approval, run run run away. Check out his pumps on the scammy $NNVC. And I mean, run!

User Image Love1010 Posted - 1 week ago

If it's got the @straynut stamp of approval, run run run away. Check out his pumps on the scammy $NNVC. And I mean, run!

User Image Love1010 Posted - 1 week ago

@skiphil @STRAYNUT Don't worry about nut job. Whatever stock he pumps fades to oblivion. Check out his many year pump on $nnvc. It is embarrassing. He blames a cabal, but clearly the company can't get anything off the ground with it's scammy approach. This company is also probably a good short.

User Image Love1010 Posted - 1 week ago

@Ally420 @STRAYNUT Ally, don't converse with this guy. Look at his posts and record on $NNVC .

User Image Love1010 Posted - 1 week ago

I feel bad for you $CODX longs as I just saw the infamous @STRAYNUT is now tracking this stock. I've been watching this poster for years pump $NNVC which is the biggest scam in the market. His predictions have been off by miles as he said $nnvc would be $200 by now, as it sits barely above a dollar. So my sense is this stock won't fare any better since he is so wrong in his calls you'd be best to bet against him. The posts are idiotic also, always blaming short cabals over incompetency. If I didn't know any better I'd have to guess he is a paid pumper. Stay away from all his calls!!! You have been warned.

User Image Love1010 Posted - 1 week ago

$NNVC Brilliance!

User Image Love1010 Posted - 1 week ago

$NNVC news flash: this company will never pull a rabbit out of a hat. What you see is what you get.

User Image STRAYNUT Posted - 2 weeks ago

$NNVC SHORT INTEREST (03/28/24) Shares Sold Short 98,916 Change from Last 13.95% Percent of Float 0.88% https://www.wsj.com/market-data/quotes/NNVC

User Image Love1010 Posted - 2 weeks ago

$NNVC top forming

User Image DavidScott Posted - 2 weeks ago

On watch tomorrow (swing trading) // Part 2 🔥📈📚 $SPCB $SIDU $NNVC $OCTO $GEVO

User Image DavidScott Posted - 2 weeks ago

$ALUR $SPCB $SIDU $NNVC $OCTO = These were our highest performers for the session. We are bullish and expecting some more momentum on these names going into Friday. If you need any guidance, or a mentor, then feel free to message me anytime! ✅🤝 Have a great rest of the day everyone! 🎉

User Image Orphan_Drug_Guy Posted - 2 weeks ago

$NNVC I've been following this company for almost 20 years, since back when they were on the pinks. If any news comes out about bird flu then the company gets a boost in pps. I have never seen one product come to fruition in 20 years. I wouldn't be surprised if the company even issues a PR about their previous workings with bird flu as they like to artificially boost pps. Of course you can always make money in these situations, but just be careful.

User Image Primitivetablemaker Posted - 3 weeks ago

$NNVC got in this morning.

User Image Love1010 Posted - 3 weeks ago

$NNVC another pumpy and dumpy....so many fools

User Image ChiefOG Posted - 3 weeks ago

$NNVC 🤔

User Image Primitivetablemaker Posted - 3 weeks ago

$NNVC

User Image Primitivetablemaker Posted - 3 weeks ago

$IGC $NNVC $NISN $TOON $LIXT . I definitely like David's picks especially NNVC.

User Image DavidScott Posted - 3 weeks ago

On watch tomorrow (swing trading) // Part 2 🔥📈📚 $IGC $NNVC $TOON $NISN $LIXT

User Image DavidScott Posted - 3 weeks ago

$SBFM $IGC $NNVC $TOON $NISN = Awesome session to kickoff the week for all of us bulls! These were our team's top favorite trades throughout the day. We are bullish and expecting some more action on these plays again tomorrow. If you need any guidance, or a mentor, then feel free to message me anytime! ✅🙌 Have a great rest of the day everyone! 🎉

User Image WhatsUpWhatsNot Posted - 3 weeks ago

$NNVC now if $HZLIF would simply take off, I can give up my PowerBall habit…

User Image drkazmd65 Posted - 3 weeks ago

$NNVC - Anybody seen any news that might be driving the rise and decent volume here today? I can't find anything posted.

User Image STRAYNUT Posted - 03/26/24

$NNVC SHORT INTEREST (03/15/24) Shares Sold Short 86,808 Change from Last -5.52% Percent of Float 0.77% https://www.wsj.com/market-data/quotes/NNVC

User Image Love1010 Posted - 1 month ago

$NNVC head and shoulders pattern emerging. Very, very bearish

User Image Love1010 Posted - 1 month ago

$NNVC stock at all time lows while market is all time highs. 10 years of dead money in the greatest bull market in history. And there is a reason. Straynut will blame a cabal. What a simpleton. The truth is no deliverables ever. Just promises. And the market is fed up with Diwan. Be happy you're above a dollar for now. Nothing here.

User Image Love1010 Posted - 1 month ago

$NNVC The RATS made the ship!

User Image Benzinga Posted - 1 month ago

NanoViricides (NASDAQ: NNVC) Hits Key Milestones For Its Virus-Fighting Drug Candidate NV-387 In 2023; More To Come This Year $NNVC https://www.benzinga.com/partner/biotech/24/03/37699420/nanoviricides-nasdaq-nnvc-hits-key-milestones-for-its-virus-fighting-drug-candidate-nv-387-in-202

Analyst Ratings
EF Hutton Buy Feb 16, 24
EF Hutton Buy Apr 18, 23